Weight Loss Linked to Increase in Pregnancy Rates
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 11, 2025 -- For women with obesity, weight-loss interventions before in vitro fertilization (IVF) are associated with an increase in total pregnancy rates and in pregnancies resulting from unassisted conception, according to a review published online Aug. 12 in the Annals of Internal Medicine.
Moscho Michalopoulou, D.Phil., from the University of Oxford in the United Kingdom, and colleagues examined whether weight-loss interventions before IVF improve reproductive outcomes in a systematic review that included randomized controlled trials (RCTs) conducted in women with obesity identified from five electronic databases. Twelve RCTs were included, with 1,921 participants; seven of the trials had a high risk for bias.
The researchers found moderate certainty that pre-IVF weight loss interventions were associated with an increase in total pregnancy rates and pregnancies resulting from unassisted conception (risk ratios, 1.21 and 1.47, respectively); an uncertain effect was seen on pregnancies resulting solely from IVF. There was no association seen for weight-loss interventions with pregnancy weight-loss rates, while the effect on live birth rates was not clear.
"In conclusion, preconception weight loss in women with obesity seeking IVF increases the chances of pregnancy, especially through unassisted conception, which may negate the need for treatment, and does not seem to increase the risk for pregnancy loss," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024
THURSDAY, Aug. 14, 2025 -- In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August...
Socioeconomic Deprivation Tied to Neurodegeneration in Combat Athletes
THURSDAY, Aug. 14, 2025 -- Athletes experiencing early-life socioeconomic disadvantage may have an increased risk for neurodegeneration from exposure to repetitive head injury...
ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes
THURSDAY, Aug. 14, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.